Rindal D Brad, Asche Stephen E, Kane Sheryl, Truitt Anjali R, Worley Donald C, Davin Lauryn M, Gryczynski Jan, Mitchell Shannon G
HealthPartners Institute, Minneapolis, MN, USA.
Friends Research Institute, Baltimore, MD, USA.
J Pain Res. 2021 Oct 20;14:3309-3319. doi: 10.2147/JPR.S330598. eCollection 2021.
Reports examining opioid prescribing for dental conditions are limited and do not examine patient-level factors. This study examines the association of patient age, sex, race, ethnicity, Medicaid coverage, and the need for an interpreter in addition to procedure type and dental provider type with receipt of an opioid prescription in dental care settings within a large health system.
This study was conducted utilizing data from the electronic health record of HealthPartners, a large dental practice embedded within a health care system. The analytic sample consisted of all 169,173 encounters from 90,487 patients undergoing a dental procedure in the baseline period (9/1/2018 to 8/30/2019), prior to implementing a clinical trial to de-implement opioids in dentistry.
Opioids were prescribed at 1.9% of all 169,173 encounters and rates varied by patient factors, procedure category, and provider type. Opioid prescriptions were most likely for extraction encounters (25.9%). In a multivariable analysis of 8760 extraction encounters, all patient age groups were more likely than those age 66+ to receive an opioid prescription, particularly those age 18-25 (OR=6.94). Patients having a complex rather than simple extraction were more likely to receive an opioid prescription (OR=6.31) and those seen by an oral surgeon rather than a general dentist (OR=9.11) were more likely to receive an opioid prescription. Among 108,748 encounters with a diagnostic procedure, opioid prescribing was more likely among male than female patients (OR=1.20), Black patients relative to White (OR=1.69), patients with Medicaid coverage (OR=1.86), and patients seeing an oral surgeon rather than a general dentist (OR=27.81).
Opioid prescribing rates vary considerably depending on procedure type. Patterns of associations between patient factors and opioid prescribing also vary considerably across procedure type. To understand which patient groups are more at risk of being prescribed opioids, it is essential to consider the procedures they are receiving.
关于牙科疾病阿片类药物处方的报告有限,且未考察患者层面的因素。本研究考察了患者年龄、性别、种族、族裔、医疗补助覆盖情况、是否需要口译员,以及手术类型和牙科医疗服务提供者类型与在一个大型医疗系统内的牙科护理环境中开具阿片类药物处方之间的关联。
本研究利用了HealthPartners电子健康记录中的数据,HealthPartners是一个嵌入医疗保健系统的大型牙科诊所。分析样本包括在基线期(2018年9月1日至2019年8月30日)90487例接受牙科手术患者的所有169173次诊疗记录,该时期先于一项在牙科中减少阿片类药物使用的临床试验实施。
在所有169173次诊疗记录中,1.9%的记录开具了阿片类药物处方,且开具率因患者因素、手术类别及医疗服务提供者类型而异。阿片类药物处方最常见于拔牙诊疗(25.9%)。在对8760次拔牙诊疗的多变量分析中,所有年龄组的患者比66岁及以上的患者更有可能收到阿片类药物处方,尤其是18 - 25岁的患者(比值比=6.94)。进行复杂拔牙而非简单拔牙的患者更有可能收到阿片类药物处方(比值比=6.31),由口腔外科医生而非普通牙医诊疗的患者更有可能收到阿片类药物处方(比值比=9.11)。在108748次诊断性手术诊疗记录中,男性患者比女性患者更有可能开具阿片类药物处方(比值比=1.20),黑人患者相对于白人患者(比值比=1.69),有医疗补助覆盖的患者(比值比=1.86),以及由口腔外科医生而非普通牙医诊疗的患者(比值比=27.81)。
阿片类药物的处方率因手术类型而异。患者因素与阿片类药物处方之间的关联模式在不同手术类型中也有很大差异。为了解哪些患者群体开具阿片类药物的风险更高,考虑他们所接受的手术至关重要。